Annual D&A
$19.84 M
-$4.33 M-17.93%
31 December 2023
Summary:
CRISPR Therapeutics AG annual depreciation & amortization is currently $19.84 million, with the most recent change of -$4.33 million (-17.93%) on 31 December 2023. During the last 3 years, it has risen by +$10.65 million (+116.00%). CRSP annual D&A is now -17.93% below its all-time high of $24.17 million, reached on 31 December 2022.CRSP Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$4.74 M
-$106.00 K-2.19%
30 September 2024
Summary:
CRISPR Therapeutics AG quarterly depreciation & amortization is currently $4.74 million, with the most recent change of -$106.00 thousand (-2.19%) on 30 September 2024. Over the past year, it has dropped by -$186.00 thousand (-3.78%). CRSP quarterly D&A is now -34.81% below its all-time high of $7.27 million, reached on 30 June 2022.CRSP Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$19.32 M
-$186.00 K-0.95%
30 September 2024
Summary:
CRISPR Therapeutics AG TTM depreciation & amortization is currently $19.32 million, with the most recent change of -$186.00 thousand (-0.95%) on 30 September 2024. Over the past year, it has dropped by -$1.47 million (-7.05%). CRSP TTM D&A is now -22.40% below its all-time high of $24.89 million, reached on 30 June 2022.CRSP TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRSP Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.9% | -3.8% | -7.0% |
| 3 y3 years | +116.0% | -11.0% | +35.5% |
| 5 y5 years | +463.7% | +269.4% | +355.8% |
CRSP Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -17.9% | +116.0% | -34.8% | at low | -22.4% | +35.5% |
| 5 y | 5 years | -17.9% | +463.7% | -34.8% | +269.4% | -22.4% | +355.8% |
| alltime | all time | -17.9% | >+9999.0% | -34.8% | +4370.8% | -22.4% | >+9999.0% |
CRISPR Therapeutics AG Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.74 M(-2.2%) | $19.32 M(-1.0%) |
| June 2024 | - | $4.84 M(+0.2%) | $19.50 M(-0.6%) |
| Mar 2024 | - | $4.83 M(-1.4%) | $19.62 M(-1.1%) |
| Dec 2023 | $19.84 M(-17.9%) | $4.90 M(-0.5%) | $19.84 M(-4.6%) |
| Sept 2023 | - | $4.92 M(-0.7%) | $20.78 M(-0.4%) |
| June 2023 | - | $4.96 M(-1.8%) | $20.88 M(-10.0%) |
| Mar 2023 | - | $5.05 M(-13.6%) | $23.18 M(-4.1%) |
| Dec 2022 | $24.17 M(+34.6%) | $5.85 M(+16.5%) | $24.17 M(-1.7%) |
| Sept 2022 | - | $5.02 M(-31.0%) | $24.59 M(-1.2%) |
| June 2022 | - | $7.27 M(+20.4%) | $24.89 M(+17.0%) |
| Mar 2022 | - | $6.04 M(-3.5%) | $21.28 M(+18.5%) |
| Dec 2021 | $17.95 M(+95.5%) | $6.26 M(+17.6%) | $17.95 M(+25.9%) |
| Sept 2021 | - | $5.32 M(+45.7%) | $14.26 M(+26.5%) |
| June 2021 | - | $3.65 M(+34.5%) | $11.27 M(+14.9%) |
| Mar 2021 | - | $2.71 M(+5.8%) | $9.81 M(+6.8%) |
| Dec 2020 | $9.18 M | $2.57 M(+9.9%) | $9.18 M(+14.1%) |
| Sept 2020 | - | $2.33 M(+6.5%) | $8.05 M(+15.0%) |
| June 2020 | - | $2.19 M(+4.8%) | $7.00 M(+16.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $2.09 M(+46.0%) | $6.00 M(+27.1%) |
| Dec 2019 | $4.72 M(+34.3%) | $1.43 M(+11.6%) | $4.72 M(+11.5%) |
| Sept 2019 | - | $1.28 M(+7.1%) | $4.24 M(+10.4%) |
| June 2019 | - | $1.20 M(+47.5%) | $3.84 M(+9.5%) |
| Mar 2019 | - | $812.00 K(-14.1%) | $3.50 M(-0.4%) |
| Dec 2018 | $3.52 M(+16.4%) | $945.00 K(+7.0%) | $3.52 M(+4.1%) |
| Sept 2018 | - | $883.00 K(+2.1%) | $3.38 M(+2.8%) |
| June 2018 | - | $865.00 K(+4.7%) | $3.29 M(+5.1%) |
| Mar 2018 | - | $826.00 K(+2.5%) | $3.13 M(+3.5%) |
| Dec 2017 | $3.02 M(+226.9%) | $806.00 K(+1.8%) | $3.02 M(+15.0%) |
| Sept 2017 | - | $792.00 K(+12.2%) | $2.63 M(+26.8%) |
| June 2017 | - | $706.00 K(-1.9%) | $2.07 M(+34.8%) |
| Mar 2017 | - | $720.00 K(+74.8%) | $1.54 M(+66.4%) |
| Dec 2016 | $925.00 K(+628.3%) | $412.00 K(+74.6%) | $925.00 K(+80.3%) |
| Sept 2016 | - | $236.00 K(+38.0%) | $513.00 K(+85.2%) |
| June 2016 | - | $171.00 K(+61.3%) | $277.00 K(+161.3%) |
| Mar 2016 | - | $106.00 K | $106.00 K |
| Dec 2015 | $127.00 K(+234.2%) | - | - |
| Dec 2014 | $38.00 K | - | - |
FAQ
- What is CRISPR Therapeutics AG annual depreciation & amortization?
- What is the all time high annual D&A for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual D&A year-on-year change?
- What is CRISPR Therapeutics AG quarterly depreciation & amortization?
- What is the all time high quarterly D&A for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly D&A year-on-year change?
- What is CRISPR Therapeutics AG TTM depreciation & amortization?
- What is the all time high TTM D&A for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG TTM D&A year-on-year change?
What is CRISPR Therapeutics AG annual depreciation & amortization?
The current annual D&A of CRSP is $19.84 M
What is the all time high annual D&A for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual depreciation & amortization is $24.17 M
What is CRISPR Therapeutics AG annual D&A year-on-year change?
Over the past year, CRSP annual depreciation & amortization has changed by -$4.33 M (-17.93%)
What is CRISPR Therapeutics AG quarterly depreciation & amortization?
The current quarterly D&A of CRSP is $4.74 M
What is the all time high quarterly D&A for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly depreciation & amortization is $7.27 M
What is CRISPR Therapeutics AG quarterly D&A year-on-year change?
Over the past year, CRSP quarterly depreciation & amortization has changed by -$186.00 K (-3.78%)
What is CRISPR Therapeutics AG TTM depreciation & amortization?
The current TTM D&A of CRSP is $19.32 M
What is the all time high TTM D&A for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high TTM depreciation & amortization is $24.89 M
What is CRISPR Therapeutics AG TTM D&A year-on-year change?
Over the past year, CRSP TTM depreciation & amortization has changed by -$1.47 M (-7.05%)